Preventive Approach for the Management of the Main Geriatric Risks

Geriatric Syndromes Clinical Trial

— Ger-e-Tec  

Official title:

Development of a Codified Preventive Approach for the Management of the Main Geriatric Risks

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05128097
• Other study ID #: 7792
• Status: Recruiting
• Start date: June 1, 2020
• Est. completion date: December 31, 2021

Study information

• Verified date: October 2021
• Source: University Hospital, Strasbourg, France
• Contact: Emmanuel ANDRES, MD, PhD
• Phone: 33 3 88 11 50 66
• Email: emmanuel.andres[@]chru-strasbourg.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Nowadays, EHPAD residents are polypathological (cognitive and psycho-behavioral pathologies, undernutrition, IC, diabetes, COPD, IR, etc.) and multi-medicated. From a medical point of view, this implies the need for regular monitoring and a high level of medical or even multidisciplinary expertise for the healthcare team. The objective of the GER-e-TEC ™ project is to provide these complex patients with telemedicine tools allowing protocolized and personalized, non-intrusive monitoring. The GER-e-TEC ™ project more specifically takes into account the significant issues in nursing homes of aging residents with the main geriatric syndromes (fall, undernutrition, cognitive-behavioral disorders, iatropathogeny, etc.) The objective of the work undertaken is to develop a codified preventive approach for the management of the main geriatric risks, in order to avoid the occurrence of an acute decompensation factor in the elderly.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 107
• Est. completion date: December 31, 2021
• Est. primary completion date: December 31, 2021
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion criteria:

• Major subject (=65 years old)

• Subject hospitalized between June 17, 2019 to November 13, 2019, in the UF 3723 department, of the Medical Clinic B of the University Hospitals of Strasbourg

• Having not expressed his opposition, after information, to the reuse of his data for the purposes of this research.

Exclusion criteria:

• Subject having expressed opposition to participating in the study

• Impossibility of providing the subject with enlightened information (difficulties in understanding the subject, etc.)

• Subject under guardianship or guardianship

• Subject under safeguard of justice

• Subject in palliative / end of life situation

• Subject in acute emergency situation

Related Conditions & MeSH terms

• Geriatric Syndromes
• Syndrome

Locations

Country	Name	City	State
France	Médecine interne, Diabète, et Maladies Métaboliques - Hôpitaux Universitaires de Strasbourg	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Retrospective study of the management of the main geriatric risks in the University HÔptaux de Strasbourg		Files analysed retrospectively from from June 17, 2019 to November 13, 2019 will be examined]